Jazz Pharmaceuticals plc Form D Notices of Exempt Offering of Securities
Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.
- 2009-11-27: Federal exemption Rule 506; Types of securities offered OptionToAcquire; SecurityToBeAcquired; "Offering of a warrant to purchase 220,000 shares of Common Stock (""Warrant"") and the underlying shares of Common Stock issuable upon exercise of Warrant."; Date of first sale 2008-05-07; Total offering amount $2,024,000.
- 2009-11-27: Federal exemption Rule 506; Types of securities offered Debt; OptionToAcquire; SecurityToBeAcquired; "Offering of $80.0 million principal amount of Senior Secured Notes (""Notes""), warrants to purchase 785,728 shares of Common Stock (""Warrants"") and the underlying shares of Common Stock issuable upon exercise of Warrants."; Date of first sale 2005-06-24; Total offering amount $87,338,700.
- 2009-11-25: Federal exemption Rule 506; Types of securities offered Debt; OptionToAcquire; SecurityToBeAcquired; "Offering of $120.0 million principal amount of Senior Secured Notes (""Notes""), warrants to purchase 562,192 shares of Common Stock (""Warrants"") and the underlying shares of Common Stock issuable upon exercise of Warrants."; Date of first sale 2008-03-14; Total offering amount $125,250,873.
| Filed | Federal exemption | Types of securities offered | Date of first sale | Total offering amount | Total amount sold | Total remaining to be sold | Investors who have already invested |
|---|---|---|---|---|---|---|---|
| 2009-11-27 D/A | Rule 506 | OptionToAcquire; SecurityToBeAcquired; "Offering of a warrant to purchase 220,000 shares of Common Stock (""Warrant"") and the underlying shares of Common Stock issuable upon exercise of Warrant." | 2008-05-07 | $2,024,000 | $0 | $2,024,000 | 1 |
| 2009-11-27 D/A | Rule 506 | Debt; OptionToAcquire; SecurityToBeAcquired; "Offering of $80.0 million principal amount of Senior Secured Notes (""Notes""), warrants to purchase 785,728 shares of Common Stock (""Warrants"") and the underlying shares of Common Stock issuable upon exercise of Warrants." | 2005-06-24 | $87,338,700 | $80,000,000 | $7,338,700 | 12 |
| 2009-11-25 D/A | Rule 506 | Debt; OptionToAcquire; SecurityToBeAcquired; "Offering of $120.0 million principal amount of Senior Secured Notes (""Notes""), warrants to purchase 562,192 shares of Common Stock (""Warrants"") and the underlying shares of Common Stock issuable upon exercise of Warrants." | 2008-03-14 | $125,250,873 | $120,000,000 | $5,250,873 | 12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |